146 related articles for article (PubMed ID: 18294446)
1. A highly sensitive high-throughput luminescence assay for malonyl-CoA decarboxylase.
Lo MC; Wang M; Kim KW; Busby J; Yamane H; Zondlo J; Yuan C; Young SW; Xiao SH
Anal Biochem; 2008 May; 376(1):122-30. PubMed ID: 18294446
[TBL] [Abstract][Full Text] [Related]
2. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
3. Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells.
Zhou W; Tu Y; Simpson PJ; Kuhajda FP
Oncogene; 2009 Aug; 28(33):2979-87. PubMed ID: 19543323
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship of small-molecule malonyl coenzyme A decarboxylase inhibitors.
Cheng JF; Chen M; Wallace D; Tith S; Haramura M; Liu B; Mak CC; Arrhenius T; Reily S; Brown S; Thorn V; Harmon C; Barr R; Dyck JR; Lopaschuk GD; Nadzan AM
J Med Chem; 2006 Mar; 49(5):1517-25. PubMed ID: 16509570
[TBL] [Abstract][Full Text] [Related]
5. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
Lane MD; Wolfgang M; Cha SH; Dai Y
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
[TBL] [Abstract][Full Text] [Related]
6. Assay of the activity of malonyl-coenzyme A decarboxylase by gas chromatography-mass spectrometry.
Wang X; Stanley WC; Darrow CJ; Brunengraber H; Kasumov T
Anal Biochem; 2007 Apr; 363(2):169-74. PubMed ID: 17316539
[TBL] [Abstract][Full Text] [Related]
7. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
Folmes CD; Lopaschuk GD
Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
[TBL] [Abstract][Full Text] [Related]
8. Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion.
Ussher JR; Lopaschuk GD
Basic Res Cardiol; 2009 Mar; 104(2):203-10. PubMed ID: 19242641
[TBL] [Abstract][Full Text] [Related]
9. Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle.
Bouzakri K; Austin R; Rune A; Lassman ME; Garcia-Roves PM; Berger JP; Krook A; Chibalin AV; Zhang BB; Zierath JR
Diabetes; 2008 Jun; 57(6):1508-16. PubMed ID: 18314420
[TBL] [Abstract][Full Text] [Related]
10. Expression of genes regulating malonyl-CoA in human skeletal muscle.
Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
[TBL] [Abstract][Full Text] [Related]
11. MCD encodes peroxisomal and cytoplasmic forms of malonyl-CoA decarboxylase and is mutated in malonyl-CoA decarboxylase deficiency.
Sacksteder KA; Morrell JC; Wanders RJ; Matalon R; Gould SJ
J Biol Chem; 1999 Aug; 274(35):24461-8. PubMed ID: 10455107
[TBL] [Abstract][Full Text] [Related]
12. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
Ussher JR; Lopaschuk GD
Cardiovasc Res; 2008 Jul; 79(2):259-68. PubMed ID: 18499682
[TBL] [Abstract][Full Text] [Related]
13. Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease.
Lopaschuk GD; Stanley WC
Cardiovasc Drugs Ther; 2006 Dec; 20(6):433-9. PubMed ID: 17136490
[TBL] [Abstract][Full Text] [Related]
14. Impaired mitochondrial fatty acid oxidative flux in fibroblasts from a patient with malonyl-CoA decarboxylase deficiency.
Bennett MJ; Harthcock PA; Boriack RL; Cohen JC
Mol Genet Metab; 2001 Jul; 73(3):276-9. PubMed ID: 11461195
[TBL] [Abstract][Full Text] [Related]
15. Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle.
Kuhl JE; Ruderman NB; Musi N; Goodyear LJ; Patti ME; Crunkhorn S; Dronamraju D; Thorell A; Nygren J; Ljungkvist O; Degerblad M; Stahle A; Brismar TB; Andersen KL; Saha AK; Efendic S; Bavenholm PN
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1296-303. PubMed ID: 16434556
[TBL] [Abstract][Full Text] [Related]
16. Pig muscle carnitine palmitoyltransferase I (CPTI beta), with low Km for carnitine and low sensitivity to malonyl-CoA inhibition, has kinetic characteristics similar to those of the rat liver (CPTI alpha) enzyme.
Relat J; Nicot C; Gacias M; Woldegiorgis G; Marrero PF; Haro D
Biochemistry; 2004 Oct; 43(39):12686-91. PubMed ID: 15449958
[TBL] [Abstract][Full Text] [Related]
17. Malonyl-CoA decarboxylase is present in the cytosolic, mitochondrial and peroxisomal compartments of rat hepatocytes.
Joly E; Bendayan M; Roduit R; Saha AK; Ruderman NB; Prentki M
FEBS Lett; 2005 Dec; 579(29):6581-6. PubMed ID: 16298369
[TBL] [Abstract][Full Text] [Related]
18. A characteristic Glu17 residue of pig carnitine palmitoyltransferase 1 is responsible for the low Km for carnitine and the low sensitivity to malonyl-CoA inhibition of the enzyme.
Relat J; Pujol-Vidal M; Haro D; Marrero PF
FEBS J; 2009 Jan; 276(1):210-8. PubMed ID: 19049515
[TBL] [Abstract][Full Text] [Related]
19. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia.
Stanley WC; Morgan EE; Huang H; McElfresh TA; Sterk JP; Okere IC; Chandler MP; Cheng J; Dyck JR; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2304-9. PubMed ID: 16100246
[TBL] [Abstract][Full Text] [Related]
20. Malonyl-CoA decarboxylase is a major regulator of myocardial fatty acid oxidation.
Cuthbert KD; Dyck JR
Curr Hypertens Rep; 2005 Dec; 7(6):407-11. PubMed ID: 16386195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
